Borosil Scientific confirms NIL encumbrance on promoter shares

1 min read     Updated on 18 Jun 2026, 03:47 AM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Borosil Scientific Limited confirmed that its promoters and persons acting in concert (PAC) have not encumbered any equity shares during the financial year ended March 31, 2026. As of the same date, the number of encumbered shares stands at NIL. This declaration was submitted in compliance with Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

powered bylight_fuzz_icon
43280256

*this image is generated using AI for illustrative purposes only.

Borosil Scientific Limited confirmed that its promoters and persons acting in concert (PAC) hold no encumbered equity shares as of March 31, 2026. The declaration, submitted by Promoter Pradeep Kumar Kheruka, states that no shares were pledged or encumbered directly or indirectly during the financial year ended March 31, 2026. This disclosure ensures shareholders that the promoter group's shareholding remains free from liabilities that could impact corporate control.

The confirmation was provided in compliance with Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The regulation mandates periodic disclosures regarding the encumbrance status of shares held by promoters and PACs to maintain transparency in the capital markets.

Persons Acting in Concert

The declaration was made on behalf of the promoters and the following entities identified as persons acting in concert:

Sr. No. Name of Shareholders
1 Kiran Kheruka
2 Rekha Kheruka
3 Pradeep Kumar Kheruka
4 Shreevar Kheruka
5 Gujarat Fusion Glass LLP
6 Spartan Trade Holdings LLP
7 Borosil Holdings LLP
8 Associated Fabricators LLP
9 Sonargaon Properties LLP
10 Croton Trading Private Limited
11 Alaknanda Ruia

The filing was addressed to the BSE Limited, the National Stock Exchange of India Ltd, and the Audit Committee of Borosil Scientific Limited on April 02, 2026.

Historical Stock Returns for BOROSCI

1 Day5 Days1 Month6 Months1 Year5 Years
+0.52%+1.86%+30.21%+31.79%+9.93%-1.27%

How might the zero-encumbrance status influence Borosil Scientific's ability to raise future capital or secure loans?

What impact will this disclosure have on institutional investor confidence and stock liquidity?

Does this signal a potential shift in the promoter group's strategy regarding mergers, acquisitions, or divestitures?

Borosil Scientific FY26 PAT rises 13.4% to ₹39.7 crore

1 min read     Updated on 28 May 2026, 05:27 AM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Borosil Scientific reported a 13.4% rise in FY26 standalone net profit to ₹39.7 crore, with consolidated PAT growing 29.4% to ₹34.6 crore. Revenue increased 6.6% to ₹467.3 crore, driven by the Scientific segment. Exceptional items of ₹8.53 crore included VRS costs and Labour Code provisions.

powered bylight_fuzz_icon
40237884

*this image is generated using AI for illustrative purposes only.

Borosil Scientific Limited has reported its audited financial results for the year ended March 31, 2026. The company posted a consolidated net profit of ₹34.6 crore for FY26, a 29.4% increase from ₹26.7 crore in the previous year. Total consolidated revenue rose 6.6% to ₹467.3 crore from ₹438.5 crore in FY25. The standalone net profit stood at ₹39.7 crore, up 13.4% year-on-year, with revenue from operations reaching ₹42.75 crore.

Financial Performance

For the quarter ended March 31, 2026, the standalone net profit was ₹21.5 crore on revenue of ₹131.9 crore. On a consolidated basis, Q4FY26 net profit surged to ₹27.2 crore from ₹8.6 crore in the corresponding period of the previous year, while revenue grew 10.6% to ₹143.2 crore. The company's board approved the financial statements on May 20, 2026.

Metric Year Ended Mar 31, 2026 (₹ in crore) Year Ended Mar 31, 2025 (₹ in crore)
Revenue from Operations 42.75 39.25
Total Income 43.77 40.03
Total Expenses 37.54 35.19
Net Profit for the Year 39.72 35.02

Operational Highlights

The financial results included exceptional items amounting to ₹8.53 crore. This comprised an expenditure of ₹6.61 crore related to a Voluntary Retirement Scheme (VRS) at the Ambad, Nashik plant and a one-time provision of ₹1.92 crore due to newly introduced Labour Codes. The company noted that despite one-time expenses related to discontinued operations at the Ambad plant, Standalone EBITDA grew during the year. Consolidated PAT was further supported by the recognition of Deferred Tax Assets in Goel Scientific Glass Works Limited.

Segment Performance

The Scientific segment led growth, with consolidated sales for FY26 reaching ₹330.9 crore, a 6.8% increase. The Glassware segment recorded sales of ₹130.8 crore. For Q4FY26, consolidated sales in the Scientific segment stood at ₹109.6 crore, while the Glassware segment contributed ₹31.8 crore. The company attributed the Q4 EBITDA improvement to higher sales and enhanced production efficiency, alongside a one-time income from the reversal of provisions at Goel Scientific Glass Works Limited.

Historical Stock Returns for BOROSCI

1 Day5 Days1 Month6 Months1 Year5 Years
+0.52%+1.86%+30.21%+31.79%+9.93%-1.27%

How will the cost savings from the Ambad plant VRS and closure impact operating margins in FY27?

What is the company's strategy to sustain the 6.8% growth in the Scientific segment amidst potential market slowdowns?

Will the recognition of Deferred Tax Assets at Goel Scientific Glass Works significantly boost future consolidated profitability?

More News on BOROSCI

1 Year Returns:+9.93%